Evidence map›Paper›PMID 26912969›Full record

ArticleMolecular vision2016

Involvement of TonEBP/NFAT5 in osmoadaptative response of human retinal pigmented epithelial cells to hyperosmolar stress.

Sarah Libert, François Willermain, Célia Weber, Angélic Bryla, Dany Salik, Françoise Gregoire, Nargis Bolaky, Laure Caspers, Jason Perret, Christine Delporte

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sarah LibertLaboratory of Pathophysiological and Nutritional Biochemistry, Erasme, Brussels, Belgium; Department of Ophthalmology, CHU Saint-Pierre and Brugmann, Brussels, Belgium.
François WillermainI.R.I.B.H.M., campus Erasme, Brussels, Belgium; Department of Ophthalmology, CHU Saint-Pierre and Brugmann, Brussels, Belgium.
Célia WeberLaboratory of Pathophysiological and Nutritional Biochemistry, Erasme, Brussels, Belgium.
Angélic BrylaLaboratory of Pathophysiological and Nutritional Biochemistry, Erasme, Brussels, Belgium.
Dany SalikLaboratory of Pathophysiological and Nutritional Biochemistry, Erasme, Brussels, Belgium; Department of Ophthalmology, CHU Saint-Pierre and Brugmann, Brussels, Belgium.
Françoise GregoireLaboratory of Pathophysiological and Nutritional Biochemistry, Erasme, Brussels, Belgium.
Nargis BolakyLaboratory of Pathophysiological and Nutritional Biochemistry, Erasme, Brussels, Belgium.
Laure CaspersDepartment of Ophthalmology, CHU Saint-Pierre and Brugmann, Brussels, Belgium.
Jason PerretLaboratory of Pathophysiological and Nutritional Biochemistry, Erasme, Brussels, Belgium.
Christine DelporteLaboratory of Pathophysiological and Nutritional Biochemistry, Erasme, Brussels, Belgium.
Centre Hospitalier Universitaire Brugmann · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMacular edema, a frequently encountered complication of diabetic retinopathy (DR), results from alterations of the blood retinal barrier (BRB) and leads to modifications of the retinal pigmented epithelium (RPE) functions. Osmolar changes of the surrounding medium could be responsible for modifications of the RPE functions leading to disturbance of retinal homeostasis. The expression, activation and function of the key hyperosmolar response factor Tonicity Enhancer Binding Protein (TonEBP also called nuclear factor of activated T-cell 5 - NFTA5) was investigated in ARPE-19 cells, derived from human RPE, in response to hyperosmolar stimulation.

methodsARPE-19 cells were exposed to hyperosmolar medium. TonEBP mRNA and protein levels were quantified by qRT-PCR and semi-quantitative Western blot. TonEBP nuclear translocation was investigated by immunofluorescence. TonEBP transactivation activity was measured using a reported plasmid containing TonEBP binding sites.

resultsIn response to hyperosmolar stimulation of ARPE-19 cells, a dose-dependent increase in TonEBP mRNA and protein levels, as well as TonEBP nuclear translocation were observed. TonEBP transactivation activity was further demonstrated using a reporter plasmid containing TonEBP binding sites. A dominant negative form of TonEBP abolished NaCl-induced increase in TonEBP transactivation activity, and inhibited the increase of the target genes aldose reductase and sodium-dependent taurine transporter mRNA levels. SB203580, an inhibitor of two of the p38 protein kinase's isoforms (p38α and p38β) inhibited the TonEBP nuclear translocation and transactivation activity in ARPE-19 cells exposed to hyperosmolar stimulation.

conclusionsOur data demonstrates the involvement of TonEBP in the mechanisms responsible for osmoadaptation to hyperosmolar stress in RPE cells. Given the emerging role of TonEBP in different pathological pathways, these data open new perspectives for the analysis of the mechanisms involved in the modification of functions of the RPE during macular edema.

Indexed as

Osmotic PressureBlotting, WesternCell LineDNA PrimersEnzyme InhibitorsFluorescent Antibody Technique, IndirectGene Expression RegulationHumansImidazolesOsmolar ConcentrationPyridinesReal-Time Polymerase Chain ReactionRetinal Pigment EpitheliumRNA, MessengerSodium ChlorideTranscription FactorsDNA PrimersEnzyme InhibitorsImidazolesNFAT5 protein, humanPyridinesRNA, MessengerSB 203580Sodium ChlorideTranscription Factors

Identifiers

PMID26912969
PMCPMC4745349
OpenAlexW820738555

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.